Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Yes! The Mark Cuban Cost Plus Drug Company sells cheaper generic drugs for diabetes, cancer, high blood pressure, HIV, hepatitis and more.
HIV clinics could lose over $100 million each year—notably those serving Black, brown, queer and Southern communities.
Several formulations of generic Truvada are now available at a lower cost.
Teva’s new version of TDF and emtricitabine doesn’t offer much of a price break, but that could come next spring.
A low-cost generic version of Truvada as PrEP will hit the market September 30.
Fact-checkers and HIV advocates break down the president’s State of the Union boasts.
A new lawsuit accuses the imprisoned hedge funder of blocking generic rivals of an AIDS-related drug.
“This is excellent news for all children living with HIV.”
The FDA has found a probable cancer-causing contaminant in generic drugs shipped from abroad––most recently, Zantac (ranitidine).
At the center of the lawsuit is Teva Pharmaceutical, slated to sell a generic version of the HIV prevention pill PrEP next year.
The head of the Food and Drug Administration cited a long commute and time away from family as reasons to step down.
U.S. activists unveil a national action plan to #BreakThePatent. It points out that taxpayers funded the research behind Truvada as PrEP.
Stocks of drug companies are rising—and that’s not a good sign for consumers.
The FDA commissioner wants drugmakers to “end the shenanigans.”
However, Gilead Sciences, the brand-name manufacturer of Truvada, insists a generic version “will not be immediately available.”
Scott Gottlieb has said he wants lower costs and faster drug approvals.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.